The Role of Thrombelastography in Multiple Trauma by Jeger, Victor et al.
Hindawi Publishing Corporation
Emergency Medicine International
Volume 2011, Article ID 895674, 4 pages
doi:10.1155/2011/895674
Review Article
The Role of Thrombelastography in Multiple Trauma
Victor Jeger, HeinzZimmermann,and Aristomenis K. Exadaktylos
Department of Emergency Medicine, University Hospital Inselspital, 3010 Bern, Switzerland
Correspondence should be addressed to Aristomenis K. Exadaktylos, exadaktylos@exadaktylos.ch
Received 22 May 2011; Accepted 7 July 2011
Academic Editor: Lee A. Wallis
Copyright © 2011 Victor Jeger et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hemorrhage and traumatic coagulopathyis are major causes of early death in multiply injured patients. Thrombelastography
(TEG) seems to be a fast and accurate coagulation test in trauma care. We suggest that multiply injured trauma patients would
beneﬁt the most from an early assessment of coagulation by TEG, mainly RapidTEG, to detect an acute traumatic coagulopathy
and especially primary ﬁbrinolysis, which is related with high mortality. This review gives an overview on TEG and its clinical
applications.
1.Introduction
Hemorrhage is a major cause of early death in multiply in-
jured patients. One of the reasons of uncontrolled hem-
orrhage may be acute traumatic coagulopathy. It has been
ﬁrst discussed by Brohi and colleagues, and it is now thought
tobeinducedbytraumaandhypoperfusion[1,2].Thepath-
omechanism of acute traumatic coagulopathy is extensively
reviewed by Hess et al. [3] 25% of major trauma patients
suﬀer from coagulopathy at admission to the hospital, and
itspresenceisassociatedwithafourfoldincreaseinmortality
[2].
The initial treatment of bleeding trauma patients is not
limited any more to damage control surgery but to damage
control resuscitation, using a balanced administration of
blood products in the ratio of red blood cells: fresh frozen
plasma as 1:1 or 1:2, which is able to correct hypovolemia,
anemia, and, to a certain degree, the acute traumatic coa-
gulopathy [4, 5]. Additionally, the acute traumatic coagu-
lopathy may also occur in absence of acute bleeding, for
example, due to massive blunt injury and hypothermia. This
pattern is typical for our patients population in a Level
1 trauma center in Switzerland, where we face mainly car
accidents and injuries related to outdoor sports (skiing,
climbing,basejumping,avalanches,etc.).Insituationswhere
coagulopathy is frequent but less obvious at admission of the
patient to the resuscitation bay, the decisions should rely on
evidence based point of care devices to correct coagulopathy.
In reality, the trauma physician is somehow blinded to the
current state of coagulation because of long turnover times
of standard coagulation screening from the lab and he/she
has to base decisions on experience and gut feeling [6].
The search for appropriate point of care devices in trau-
ma care brought thrombelastography (TEG) back in focus in
1997 by Kaufmann et al. after the technique had been used
for years in cardiac and liver surgery [7, 8].
2. Thrombelastography—Assessing the
Viscoelastic Properties of the Thrombus
The concept of thrombelastography had been ﬁrst described
by Hartert in 1948 [9]. Only its development to a compact
device in combination with a computer made its ma-
nipulation easier and its measurements reproducible. The
technique had been described before and should only be
mentioned brieﬂy [7, 10, 11]. A small volume of blood (340–
360µL) is placed in an oscillating cup kept at 37◦C or at the
patient’s current temperature. A pin is suspended in the cup
from a torsion wire with an electrical transducer. Initially
there is no clot, the motion of the cup does not aﬀect the pin,
and a straight line trace is obtained. As the blood in the cup
clots however, the motion of the rotating cup is transmitted
to the pin and its oscillation is recorded (Figure 1)[ 11].
The procedure can be accelerated by activating coagulation
of the sample with kaolin, a celite, which increases the
surface (intrinsic activation), or with tissue factor (extrinsic2 Emergency Medicine International
activation, RapidTEG). Additionally, heparinase coated cups
and pins can be used to monitor coagulation properties of
thepatient’sbloodunderneathheparintherapy.Finally,there
are also kits to measure platelet function or ﬁbrinogen in
special situations, which are not discussed in this paper.
The most important TEG parameters are the reaction
time “r”, which measures the initiation of coagulation until
a ﬁrst pin oscillation of 2mm and represents initiating
coagulation factors, “K” and “alpha angle” represent the
dynamicoftheclotformationandaremeasuresoftimefrom
t h ee n do f“ r” to 20mm of pin oscillation, and the slope
between “r”a n d“ K” respectively. They correspond mainly
with ﬁbrinogen concentration. The maximal amplitude
(MA) represents clot strength and is therefore an estimation
of platelet function. Finally, LY30, which is the lysis of the
clot 30 minutes after MA, measures the rate of ﬁbrinolysis.
These parameters reﬂect the strength of thrombelastography
tomonitornotonlyonestepofthecascade-likeconventional
coagulation tests, which focus only on ﬁbrin formation. It
gives a rapid overview on the main players in the cascade
which are important to the trauma physician like initiation
factors, ﬁbrinogen, platelet function, and ﬁbrinolytic com-
ponents.
As mentioned above, TEG has evolved in an automated
device which only needs 2-3 pipetting manipulations and
not more than 2 minutes to start. It is possible to train
physicians and nurses in only one or two short sessions, even
with no previous lab experience, to run a TEG accurately.
A step by step protocol, as provided by the manufacturer,
is helpful, especially in smaller trauma units, where TEG is
not performed every day. Quality control test runs should
be performed regularly and may be attributed to the quality
control experts for point-of-care devices of your hospital.
The site of blood sampling seems not to be neglectable,
especially when comparing patients in a study or if there
is repeated measurements on the same patient. It has been
shown that there are diﬀerences between the sampling sites,
not related to the oxygen content but to the calculated shear
forces in the corresponding blood vessel [12].
Two diﬀerent but very similar devices exist to measure
thrombelastography: TEG 5000 Analyzer from Haemonetics
(Braintree, MA, USA) and ROTEM from TEM (Munich,
Germany). This paper did focus specially on the TEG device,
but the conclusions from the current literature are applicable
for ROTEM as well.
3. AnimalStudies—TraumaModels
andCoagulopathy
In trauma research, the main limitation, even in large mul-
ticenter studies, is the high variability of the studied patient
sample. There is a heterogeneity in the injury pattern, age,
comorbidities, mechanismof injury, andin manymore. This
isthereasonwhytraumastudiesfocusingonhemodynamics,
hemorrhage control, and coagulopathy are performed with
animal models. Some recent publications are mentioned
here, which all showed that TEG is a reasonable coagulation
test in the early assessment of trauma patients.
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Figure 1: Normal TEG tracing with arrows highlighting the most
important TEG parameters (r, K, angle and MA).
That pigs are a good model for research in coagu-
lation and ﬁbrinolysis has been shown by Velik-Salchner
and colleagues [13]. White et al. worked with a pig model
for traumatic hemorrhagic shock consisting of soft tissue
injury and femur fracture. They randomized 23 pigs in 18
hemorrhage and 5 controls. With the beginning of hem-
orrhagic shock, ﬁbrinogen concentration decreased rapidly.
With increasing shock, TEG MA was reduced from 68.8
(SE: 0.9) to 64.7 (SE: 0.9). All other TEG parameters and
conventional coagulation tests remained unchanged during
hemorrhage [14]. Martini and colleagues were interested in
the eﬀect of hypothermia or hemorrhage on coagulation.
Therefore, they randomized 24 pigs in four groups (control,
hemorrhage with resuscitation, hypothermia, hemorrhage
with resuscitation, and hypothermia). PT and aPTT did
not change by hemorrhage or hypothermia. However, TEG
parameters were aﬀected by both: hypothermia prolonged
r-time and K and decreased the angle alpha, hemorrhage
only decreased MA. As only TEG was able to diﬀerentiate
the mechanism of coagulopathy, the authors suggested, that
TEG may be a suitable test to guide treatment of clotting
alterations associated with hypothermia and hemorrhagic
shock [15]. Kheirabadi et al. had a similar conclusion in a
rabbit model of coagulopathy: 21 rabbits were randomized
in three groups (control, warfarin treated, hemodiluted
hypothermia). All animals underwent splenic injury. PT was
validtomonitorwarfarin-inducedcoagulopathybutfailedto
be reliable as a screening test for dilutional and hypothermic
coagulopathy. TEG measurements of blood clotting rate
represented better coagulopathic bleeding and mortality
[16]. Finally, in a very complex pig model of multiple
injury, preclinical phase and clinical phase, Alam and col-
leagues induced an acute traumatic coagulopathy. Diﬀerent
protocols of resuscitation had an eﬀect on coagulation,
which was measured most accurately with TEG: Hetastarch
worsened coagulopathy, but it was rapidly reversed with the
administration of blood components, especially FFP [17].
4.ClinicalStudies—Describingthe
Trauma Patient
Kaufmann and colleagues studied the use of TEG in 69
blunt trauma patients and found that only Injury Severity
Score (ISS) and TEG were predictive for transfusion. TheyEmergency Medicine International 3
described that the majority of their patients studied was
hypercoagulable [8]. Schreiber et al. did also discover that
their trauma patients (n = 65) were hypercoagulable. They
used noncitrated whole blood for the kaolin-activated TEG
measurements. Mainly on day 1 (62%) compared to day 4
(26% of patients) after admission to the hospital. Women
were more hypercoagulable than men. Like in animal studies
described above, the authors did not detect pathologic con-
ventional coagulation test values, which were within normal
limits throughout the study [18]. However, the ﬁnding that
trauma patients show mainly hypercoagulable changes had
not been found by others. One explanation may be the
small sample size and the high variability among trauma
patients.Rugerietal.usedtheROTEMdeviceintheirtrauma
study (n = 88), which uses citrated whole blood. Four
consecutive measurements had been done over the ﬁrst 24
hours after admission to the ER. One third of the patients
presented a coagulopathy at the ﬁrst measurement after
admission to ER. The authors showed strong correlations of
conventional coagulation screening with the corresponding
ROTEM parameter. However, the authors did not show
the data of the evolution of ROTEM values over time, as
they pooled all the ROTEM values together to compare
and correlate them with the corresponding conventional
coagulation parameter [19].
A larger sample of trauma patients (n = 161) had been
studied by Carrol and colleagues: TEG had been performed
either tissue factor activated or using platelet mapping. One
sample was collected onsite and the second in the emergency
department (ED). The authors did not detect changes from
onsite to ED. No diﬀerences had been found between 22
patients who received blood products compared to the other
patients. Only by using the platelet mapping assay, dif-
ferencesinadpresponsivenesswereobtained.Whentheyhad
a closer look to the 14 fatalities in their sample, they found a
diﬀerence in r value and MA compared to survivors. Hyper-
ﬁbrinolysis was detected in three patients of whom two died.
The authors concluded that TEG should be used as an addi-
tional tool to standard coagulation tests, especially to moni-
tor hyperﬁbrinolysis, which is related to high mortality [20].
TEG had also been evaluated and applied in combat
support hospitals by the U.S. Army in Iraq and Afghanistan.
Plotkin et al. described 44 patients with combat injuries. A
TEG was run with noncitrated whole blood samples (kaolin
activated) within 24 hours after admission to the hospi-
tal. Conventional coagulation tests were suggesting hypo-
coagulation but did not correlate with blood product use.
However, TEG values, especially MA correlated with blood
product use platelet count [21].
To evaluate the best ratio of packed blood cells (PBC) to
fresh frozen plasma (FFP), Davenport et al. used a ROTEM
device to assess the coagulation status of 50 trauma patients
who received more than 4 units PBC. The authors stated that
a ratio of 1:2 or 3:4 should be achieved to preserve coagula-
tion and a ratio of 1:1 did not show to be better. However, if
theratiois<1:2,patientspresentedhypocoagulableROTEM
results [5].
We started a few years ago to introduce tissue factor
activated TEG (RapidTEG) in our resuscitation bay of a
level 1 trauma center in Switzerland. We found that using
noncitrated whole blood from samples drawn at admission
of the patient to resuscitation bay provided the trauma
physician with fast and accurate results about the patient’s
coagulation status. This may help to guide focused blood
product administration early in the treatment [11]. Kashuk
and colleagues were studying the use of RapidTEG in trauma
as well. In a ﬁrst study (n = 44), they were interested if
the use of noncitrated whole blood would have advantages
compared to citrated whole blood. The authors correlated
RapidTEG results with corresponding conventional coagu-
lation measurements and found slightly higher correlation
between noncitrated TEG values with CCT compared to
citrated TEG results. This led the authors to the assumption
that noncitrated samples may be more accurate. However,
they stated that it is diﬃcult to compare a static (conven-
tional) with a dynamic test (TEG) [22]. In a further study,
analyzing the data of 61 trauma patients, Kashuk et al. found
that 34% of patients requiring massive transfusion suﬀered
from primary ﬁbrinolysis. 64% of these patients sustained
penetrating injuries. RapidTEG tests had been run with
noncitrated whole blood. The authors suggested the G-value
as a measure of clot strength, (dynes/cm2) as a predictive
parameterforidentiﬁcationofﬁbrinolysis,anddeathasearly
as one hour after injury.
5. Conclusion
According to the current literature, thrombelastography
seems to be a fast and accurate coagulation test in trauma
care. We suggest that multiply injured trauma patients with
an ISS > 16 would beneﬁt the most from an early assessment
of coagulation by TEG, mainly RapidTEG, to detect an acute
traumatic coagulopathy and especially primary ﬁbrinolysis,
which is related with high mortality. Where the TEG should
be run depends on the staﬀ resources of your emergency
department. We suggest to draw citrated whole blood at the
admission of the trauma patient to the resuscitation bay and
to send it to the central hematologic lab to run the test. The
results may then be presented on a screen at the bed side.
Tieuetal.didalsosharethisopinionandstatedthatitmaybe
diﬃcult to run a TEG on noncitrated whole blood, especially
due to the handling time of less than 4 minutes after blood
sampling. This may demand multiple TEG devices in many
critical areas of a hospital. Although some eﬀects of citrated
blood on TEG values had been observed, it may be an
alternative to run a TEG on citrated whole blood in a central
lablikeconventionalcoagulationtests[23].Thismayprevent
the trauma physicians from an additional manipulation and
could give them TEG values with a better quality control and
reproducibility.
Interventionalmulticenterstudiesareneededtoestablish
the use of TEG in the trauma setting. May early TEG
results inﬂuence blood product administration and would
this change the outcome of trauma patients? Do we use the
correctTEGtransfusionthresholds?Hopefully,weareableto
answersomeofthesequestionssoontoimprovetheoutcome
of trauma patients.4 Emergency Medicine International
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